68 LNK001 is a High-Fidelity AND-Logic-Gated CAR T Cell Therapy that Enables Precision Targeting of Clear Cell Renal Cell Carcinoma (ccRCC): Target Discovery and Validation for the ATHENA Phase 1 Trial - Alexander Bankovich; Bryan Smith; Colin Farrell; Angeles Estelles; Janette Sutton; Zeynep Wheeler; Kazuteru Hasegawa; Benjamin Bauer; Jakob McBroome; Diego Vargas-Inchaustegui; Regina Lin; Mark Wallet (The Oncologist, 2026)